Verisk Analytics, Inc.’s (VRSK - Free Report) business — GeomniTM — unveiled a new subscription service, Geomni Vision.
Through this service, customers can access geospatial data for structures and parcels throughout the United States, with the help of high-resolution aerial oblique and orthogonal imagery libraries and related tools (which includes viewer, arc-GIS plug-ins, post-catastrophe machine learning data).
Geomni Vision can be accessed through Geomni`s online web viewer via plug-in applications such as ArcMap and ArcGIS Pro or with other solutions that use industry-standard WMTS APIs.
Geomni uses remote sensing technologies to refresh the aerial imagery library.
Comments From Management
Jeffrey C. Taylor, president of Geomni, stated, "The new service will significantly improve the way customers approach underwriting and insurance claims."
He further added, "Having access to the most current orthogonal and oblique aerial imagery, along with all the measurement tools, will be a vital asset to customers for risk assessment in their front-end underwriting process, resource deployment, claims processing, and claims project management.”
To Conclude
The launchis expected to help Verisk enhance its Insurance segment, which provides underwriting and ratings, and claims insurance data for the U.S. property and casualty ("P&C") insurance industry.
Performance of the segment was strong in the last reported quarter with revenues increasing 7.6% year over year on a reported basis, 6.2% organically and 6.4% on an organic constant currency basis in the last reported quarter. The segment contributed the largest chunk (around 71%) to Verisk’s fourth-quarter 2018 revenues.
Zacks Rank & Stocks to Consider
Currently, Verisk carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are Omnicom (OMC - Free Report) , Robert Half (RHI - Free Report) and Automatic Data Processing (ADP - Free Report) . While Robert Half sports a Zacks Rank #1, Omnicom and Automatic Data Processing carry a Zacks Rank #2 (Buy).
Long-term expected EPS (three to five years) growth rate for Omnicom, Robert Half and Automatic Data Processing is 6.9%, 8.4% and 12.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Verisk Analytics, Inc.’s (VRSK - Free Report) business — GeomniTM — unveiled a new subscription service, Geomni Vision.
Through this service, customers can access geospatial data for structures and parcels throughout the United States, with the help of high-resolution aerial oblique and orthogonal imagery libraries and related tools (which includes viewer, arc-GIS plug-ins, post-catastrophe machine learning data).
Geomni Vision can be accessed through Geomni`s online web viewer via plug-in applications such as ArcMap and ArcGIS Pro or with other solutions that use industry-standard WMTS APIs.
Geomni uses remote sensing technologies to refresh the aerial imagery library.
Comments From Management
Jeffrey C. Taylor, president of Geomni, stated, "The new service will significantly improve the way customers approach underwriting and insurance claims."
He further added, "Having access to the most current orthogonal and oblique aerial imagery, along with all the measurement tools, will be a vital asset to customers for risk assessment in their front-end underwriting process, resource deployment, claims processing, and claims project management.”
To Conclude
The launchis expected to help Verisk enhance its Insurance segment, which provides underwriting and ratings, and claims insurance data for the U.S. property and casualty ("P&C") insurance industry.
Performance of the segment was strong in the last reported quarter with revenues increasing 7.6% year over year on a reported basis, 6.2% organically and 6.4% on an organic constant currency basis in the last reported quarter. The segment contributed the largest chunk (around 71%) to Verisk’s fourth-quarter 2018 revenues.
Zacks Rank & Stocks to Consider
Currently, Verisk carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Some better-ranked stocks in the broader Zacks Business Services sector are Omnicom (OMC - Free Report) , Robert Half (RHI - Free Report) and Automatic Data Processing (ADP - Free Report) . While Robert Half sports a Zacks Rank #1, Omnicom and Automatic Data Processing carry a Zacks Rank #2 (Buy).
Long-term expected EPS (three to five years) growth rate for Omnicom, Robert Half and Automatic Data Processing is 6.9%, 8.4% and 12.8%, respectively.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ADP - FREE
Get the latest research report on OMC - FREE
Get the latest research report on RHI - FREE
Get the latest research report on VRSK - FREE